markets · · proactiveinvestors.com
Ondine Biomedical raises £10m for international commercial expansion
Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF) has raised £10 million through a placing and subscription, securing funding to support international commercial expansion and its planned US regulatory submission in mid-2027. The medical technology company is issuing 100 million new shares at 10p apiece, with proceeds expected to extend its cash runway into early 2028.
Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF) has raised £10 million through a placing and subscription, securing funding to support international commercial expansion and its planned US regulatory submission in mid-2027. The medical technology company is issuing 100 million new shares at 10p apiece, with proceeds expected to extend its cash runway into early 2028.
- #OBIMF